Pharmaceuticals (Jul 2021)

2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of <i>Plasmodium falciparum</i>

  • Dyhia Amrane,
  • Christophe-Sébastien Arnold,
  • Sébastien Hutter,
  • Julen Sanz-Serrano,
  • Miguel Collia,
  • Amaya Azqueta,
  • Lucie Paloque,
  • Anita Cohen,
  • Nadia Amanzougaghene,
  • Shahin Tajeri,
  • Jean-François Franetich,
  • Dominique Mazier,
  • Françoise Benoit-Vical,
  • Pierre Verhaeghe,
  • Nadine Azas,
  • Patrice Vanelle,
  • Cyrille Botté,
  • Nicolas Primas

DOI
https://doi.org/10.3390/ph14080724
Journal volume & issue
Vol. 14, no. 8
p. 724

Abstract

Read online

The malaria parasite harbors a relict plastid called the apicoplast. Although not photosynthetic, the apicoplast retains unusual, non-mammalian metabolic pathways that are essential to the parasite, opening up a new perspective for the development of novel antimalarials which display a new mechanism of action. Based on the previous antiplasmodial hit-molecules identified in the 2-trichloromethylquinoxaline series, we report herein a structure–activity relationship (SAR) study at position two of the quinoxaline ring by synthesizing 20 new compounds. The biological evaluation highlighted a hit compound (3i) with a potent PfK1 EC50 value of 0.2 µM and a HepG2 CC50 value of 32 µM (Selectivity index = 160). Nitro-containing (3i) was not genotoxic, both in the Ames test and in vitro comet assay. Activity cliffs were observed when the 2-CCl3 group was replaced, showing that it played a key role in the antiplasmodial activity. Investigation of the mechanism of action showed that 3i presents a drug response by targeting the apicoplast and a quick-killing mechanism acting on another target site.

Keywords